Clinical trial results are described as spanning roughly 5% to 22% of baseline body weight, and real-world data from compounded and branded users shows similar heterogeneity, with some people losing 5-10% and others achieving over 20%
Your journey begins with a complimentary 10-minute consultation, where we tailor a plan to your unique needs
There is no guarantee of a specific weight loss medication being prescribed
But research suggests the drugs may also reduce heart attacks and protect the brain from cognitive decline
*Prescriptions for compounded semaglutide, when available, may be prescribed as an alternative to commercially unavailable branded medications on the FDA shortage list
The results revealed significant changes in multiple metabolic pathways (Supplementary Data 6) and, unsurprisingly, the sphingolipid metabolism pathway again emerged